Hermetica Superfood Encyclopedia
The Short Answer
Matico leaves contain high concentrations of polyphenols—including catechin (682 mg/100 g dw in flowers), quercetin, rutin, luteolin, caffeic acid, and the iridoid 6-O-methylcatalpol—that scavenge free radicals, disrupt microbial proliferation, and inhibit inflammatory pathways. In vitro, methanolic leaf extracts demonstrate robust antioxidant capacity (DPPH: 849.7 ± 27.4 μmol TE/g dw; FRAP: 1021.5 ± 33.6 μmol TE/g dw) and selectively inhibit Trypanosoma cruzi trypomastigotes at IC50 280 μg/mL with a selectivity index greater than 15–20 versus mammalian Vero cells.
CategoryHerb
GroupAmazonian
Evidence LevelPreliminary
Primary Keywordmatico benefits
Matico — botanical close-up
Health Benefits
**Anti-inflammatory Activity**
Flavonoids quercetin and luteolin, concentrated in methanolic leaf extracts (TFC 271.1 ± 3.0 μmol QE/g dw), inhibit pro-inflammatory enzyme cascades, supporting the traditional use of Matico infusions to relieve muscle pain, sore throats, and soft-tissue inflammation.
**Potent Antioxidant Protection**: Total phenolic content of 1614
7 ± 105.9 μmol GAE/g dw and ORAC values reaching 134,147 μmol Trolox Eq/100 g dw indicate exceptional radical-scavenging capacity, with BG400 and BG600 fractions showing the highest ABTS activity due to optimal intermediate-polarity compounds.
**Antimicrobial and Antibiofilm Effects**
Spray-dried Buddleja globosa preparations inhibit Pseudomonas aeruginosa proliferation at a MIC of 512 μg/mL catechin equivalents and suppress biofilm formation, suggesting utility against drug-tolerant bacterial communities.
**Antiparasitic Activity Against Trypanosoma cruzi**
Methanolic extract (IC50 280 ± 3.5 μg/mL) and iridoid-enriched BG500 fraction (IC50 358 ± 4.2 μg/mL) selectively destroy T. cruzi trypomastigotes in vitro, with selectivity indices exceeding 15–20 relative to mammalian cells, positioning Matico as a candidate adjunct in Chagas disease research.
**Wound Healing Support**
Traditional topical application of Matico leaf decoctions is supported by the combined presence of astringent catechins, antimicrobial polyphenols, and anti-inflammatory iridoids that together reduce microbial load and moderate inflammatory signaling at wound sites.
**Gastrointestinal Protection**
Historical Chilean ethnomedicine employs Matico infusions for gastric inflammation and ulcer management, plausibly mediated by mucosal protection from rutin and chlorogenic acid alongside antimicrobial action on enteric pathogens.
**Broad-Spectrum Antioxidant Micronutrient Profile**
The plant supplies provitamin A carotenoids and vitamins C and E alongside its polyphenol matrix, creating additive antioxidant coverage across aqueous and lipid cellular compartments.
Origin & History
Natural habitat
Buddleja globosa is native to the temperate regions of Chile and Argentina, growing along riverbanks, roadsides, and forest edges at elevations up to 2000 meters in the Andes foothills. The shrub thrives in well-drained, moderately fertile soils under full sun and is widely cultivated in Chilean home gardens and rural farmsteads for medicinal use. It has naturalized in parts of Europe, particularly the British Isles, where it was introduced as an ornamental, though South American populations remain the primary source for medicinal preparations.
“Matico has been a cornerstone of Chilean and broader Andean ethnomedicine for centuries, with its common name deriving from a Spanish soldier named Matico who reportedly used the plant's leaves to staunch battlefield wounds—an origin story recorded in 19th-century botanical literature. In traditional Chilean herbal practice (hierbatería), leaves are gathered from wild shrubs, dried in shade, and brewed as infusions or applied as poultices for hemorrhage control, wound disinfection, gastric ulcers, sore throats, and rheumatic pain. The plant also carries cultural significance in southern Argentinian indigenous communities, where it is used similarly for skin conditions and as a bitter digestive tonic, reflecting a shared Andean ethnopharmacological tradition that predates Spanish colonization. European naturalists including Philippi and Gay documented Buddleja globosa in 19th-century Chilean flora surveys, and the plant was later introduced to British gardens as an ornamental, inadvertently expanding awareness of its medicinal reputation among European herbalists.”Traditional Medicine
Scientific Research
The evidence base for Buddleja globosa consists entirely of in vitro and phytochemical characterization studies; no human randomized controlled trials or animal efficacy models with standardized interventions have been published as of the most recent literature review. Key studies have employed UPLC-ESI-MS/MS for compound identification, DPPH/ABTS/FRAP/ORAC assays for antioxidant quantification, MTT and neutral red cytotoxicity assays in Vero and CHO-K1 cell lines, and MIC/biofilm inhibition protocols against P. aeruginosa, providing reproducible in vitro metrics but no translational dose-response data in living organisms. Antiparasitic findings against T. cruzi (IC50 280–358 μg/mL; selectivity index >15–20) are internally consistent across fractions and replicated with appropriate controls including the reference drug nifurtimox (IC50 5.0 ± 0.5 μg/mL), lending credibility to the biological activity while underscoring the large potency gap versus clinical agents. The body of research is methodologically sound at the bench level but remains at a preclinical stage, and efficacy claims for human therapeutic applications must be regarded as preliminary and hypothesis-generating.
Preparation & Dosage
Traditional preparation
**Traditional Infusion (Tea)**
5–10 g dried Matico leaves steeped in 200 mL boiling water for 10–15 minutes; consumed 2–3 times daily in Chilean folk medicine for inflammatory and gastrointestinal complaints—no clinically validated dose established
Approximately .
**Decoction**
Leaves or flowers simmered in water for 20–30 minutes; applied topically to wounds or consumed for internal anti-inflammatory effects in Andean traditional practice.
**Methanolic/Hydroalcoholic Extract**
Used in research at concentrations producing TPC 1614.7 μmol GAE/g dw; no standardized commercial supplement form with defined extract ratio is currently established.
**Spray-Dried Powder (BG-SD)**
Experimental formulation with PVP or SP excipients achieving solubility up to 2048 μg/mL catechin equivalents at 37°C; employed in antimicrobial MIC studies but not yet available as a consumer product.
**Iridoid-Enriched Fraction (BG500)**
Prepared by polarity-guided liquid-liquid fractionation; used at IC50-relevant concentrations (358 μg/mL) in antiparasitic models—no oral supplement equivalent exists.
**Standardization Note**
No international pharmacopoeial monograph or standardized extract specification (e.g., % catechin or % total polyphenols) has been formally adopted; researchers use catechin equivalents or GAE as reference markers.
Nutritional Profile
Buddleja globosa leaves and flowers contain exceptionally high polyphenol concentrations: catechin reaches 682.43 mg/100 g dw in flowers, total phenolics measure up to 1614.7 μmol GAE/g dw in methanolic extracts, and total flavonoids reach 271.1 μmol QE/g dw. Identified individual polyphenols include quercetin, rutin, luteolin, caffeic acid, chlorogenic acid, and syringic acid (0.81–1.48 mg/100 g dw depending on fraction). Reducing sugars are substantial at 6237.2 ± 55.6 mg glucose equivalents/100 g dw, suggesting appreciable carbohydrate content in the leaf matrix. The plant also supplies provitamin A carotenoids and vitamins C and E as accessory antioxidants, and the iridoid glycoside 6-O-methylcatalpol is a characteristic non-phenolic bioactive. Bioavailability of the polyphenols in humans is unstudied; catechin and quercetin from other plant sources typically show moderate oral bioavailability (20–50%) subject to gut microbiome metabolism.
How It Works
Mechanism of Action
The primary antioxidant mechanism involves hydrogen atom transfer and single-electron donation by catechin, quercetin, luteolin, rutin, and caffeic acid, neutralizing superoxide, hydroxyl, and peroxyl radicals as quantified by DPPH, ABTS, and FRAP assays; the BG400 fraction achieves peak ABTS activity because its intermediate-polarity compounds align optimally with the assay's radical environment. Anti-inflammatory activity is attributed to quercetin and luteolin inhibiting cyclooxygenase (COX) and lipoxygenase (LOX) enzymes, as well as suppressing NF-κB nuclear translocation, thereby reducing prostaglandin E2 and leukotriene synthesis. The iridoid glycoside 6-O-methylcatalpol, concentrated in the BG500 fraction, contributes antiparasitic activity by disrupting mitochondrial membrane potential and metabolic viability in Trypanosoma cruzi trypomastigotes (IC50 358 ± 4.2 μg/mL, R² >0.97), a mechanism distinct from polyphenol-driven oxidative stress. Antimicrobial polyphenols, particularly catechin and caffeic acid, destabilize bacterial cell membranes and interfere with quorum-sensing-dependent biofilm assembly in Gram-negative organisms such as P. aeruginosa.
Clinical Evidence
No human clinical trials investigating Buddleja globosa have been identified in the peer-reviewed literature; consequently, no effect sizes, confidence intervals, or patient-level outcomes are available for any indication including inflammation, wound healing, antimicrobial use, or antiparasitic therapy. The sole quantitative biological data derive from cell-culture models: antioxidant assays with μmol TE/g dw endpoints, cytotoxicity IC50 values in mammalian cell lines, and MIC values against bacterial and protozoal pathogens. While these in vitro results are consistent with the plant's traditional uses and provide a rational mechanistic foundation, they cannot be extrapolated to predict clinical efficacy, optimal human dosing, or comparative effectiveness against standard-of-care therapies. Prioritized next steps would include standardized oral bioavailability studies, followed by dose-escalation safety trials, before efficacy endpoints can be responsibly evaluated in human populations.
Safety & Interactions
In vitro toxicological data indicate low cytotoxicity toward Vero cells (IC50 >5000 μg/mL for methanolic extract) but measurable membrane and metabolic disruption in CHO-K1 ovarian cells at tested concentrations, suggesting cell-type-specific toxicity that warrants caution until human data are available. No human adverse event reports, drug interaction studies, or formally established maximum safe doses exist in the peer-reviewed literature, making definitive safety characterization impossible at this time. Theoretically, the high flavonoid content—particularly quercetin and catechin—could potentiate anticoagulant drugs (e.g., warfarin) by inhibiting platelet aggregation, and polyphenols may modulate CYP450 enzyme activity, potentially altering metabolism of co-administered pharmaceuticals. Pregnancy and lactation safety is entirely uncharacterized; in the absence of clinical data, use during pregnancy, lactation, or in pediatric populations should be avoided, and individuals on prescription medications should consult a healthcare provider before use.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Orange ball treePañilPiper aduncum (Matico)Matico (Piper aduncum)Piper aduncum (Matico / Spiked Pepper)Buddleja globosa (Matico)Maitén machoMatico Leaves (Buddleja globosa)Buddleja globosaBuddleia globosaPiper aduncum (Piper aduncum L.)
Frequently Asked Questions
What is matico used for traditionally?
In Chilean and Andean traditional medicine, matico leaves and flowers are prepared as infusions or poultices to heal wounds, control bleeding, relieve sore throats and muscle pain, ease gastrointestinal inflammation, and treat skin conditions. The practice dates back centuries in southern South America and is supported by the plant's high concentration of antimicrobial catechins and anti-inflammatory quercetin and luteolin. While these uses are ethnobotanically well-documented, no human clinical trials have yet confirmed efficacy for any specific indication.
What are the active compounds in Buddleja globosa?
Buddleja globosa contains a rich polyphenol matrix dominated by catechin (682 mg/100 g dw in flowers), quercetin, rutin, luteolin, caffeic acid, chlorogenic acid, and syringic acid, alongside the iridoid glycoside 6-O-methylcatalpol which is particularly concentrated in the BG500 fraction. Total phenolic content in methanolic leaf extracts reaches 1614.7 μmol gallic acid equivalents per gram dry weight, placing it among the more phenol-dense medicinal plants characterized to date. Accessory antioxidants include provitamin A carotenoids and vitamins C and E.
Does matico have any proven anti-inflammatory effects?
Anti-inflammatory activity has been demonstrated at the in vitro level, where flavonoids quercetin and luteolin in Matico extracts inhibit COX and LOX enzymes and suppress NF-κB signaling, the same molecular targets addressed by many pharmaceutical anti-inflammatory agents. Quantitative antioxidant assays (DPPH 849.7 ± 27.4 μmol TE/g dw; FRAP 1021.5 ± 33.6 μmol TE/g dw) confirm robust radical-scavenging capacity closely linked to inflammation resolution. However, no randomized controlled trials in humans have tested Matico for clinical anti-inflammatory endpoints, so evidence remains preclinical.
Is matico safe to take as a supplement?
Based on available data, methanolic Matico extracts show very low toxicity toward mammalian Vero cells (IC50 >5000 μg/mL), suggesting a favorable in vitro safety margin, but cytotoxicity was observed in CHO-K1 ovarian cells, indicating cell-type-specific effects that require further investigation. No human safety studies, established maximum tolerated doses, or systematic drug interaction assessments have been published, meaning the safety profile in humans is essentially unknown. Until clinical safety data exist, individuals who are pregnant, breastfeeding, or taking anticoagulant or cytochrome P450-metabolized medications should avoid use without medical supervision.
How is matico tea prepared?
The traditional Chilean preparation involves steeping approximately 5–10 g of dried Matico leaves in 200 mL of freshly boiled water for 10–15 minutes, then straining and consuming the infusion 2–3 times daily. For topical wound applications, a stronger decoction is made by simmering leaves for 20–30 minutes before cooling and applying to affected skin. No clinically validated dose has been established, and modern spray-dried or fractionated extract forms remain experimental rather than commercially standardized.
What is the most bioavailable form of matico for maximum anti-inflammatory benefits?
Methanolic leaf extracts and standardized preparations demonstrate the highest concentration of active flavonoids (quercetin and luteolin), making them more bioavailable than whole leaf material. Hot water infusions (tea) also effectively extract these compounds and are a practical, traditional delivery method with good absorption rates. Standardized extracts may offer more consistent dosing and potency compared to loose leaf preparations.
Does matico interact with common anti-inflammatory or pain relief medications?
While matico contains flavonoids that work through similar anti-inflammatory pathways as NSAIDs and corticosteroids, no major interaction studies have been published specifically for Buddleja globosa. Due to its mild nature and traditional use as a food-like herb, it is unlikely to cause significant interactions, but concurrent use with prescription anti-inflammatory medications should be discussed with a healthcare provider to avoid additive effects.
Who benefits most from matico supplementation—is it suitable for athletes or people with chronic inflammation?
Matico is particularly beneficial for individuals with mild to moderate musculoskeletal inflammation, sore throats, or soft-tissue discomfort, including athletes seeking natural anti-inflammatory support. Its high total phenolic content (1614.7 ± 105.9 μmol GAE/g dw) and antioxidant activity make it suitable for those managing exercise-induced inflammation or chronic low-grade inflammatory conditions, though it should complement rather than replace medical treatment for serious inflammatory diseases.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w matico-buddleja-globosa curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
